IP Library Assignment 060052/0786
Patent Assignment
Reel/Frame 060052/0786

Release of Security Interest

Recorded: 2022-05-31 Pages: 8
Assignor
BANK OF AMERICA, N.A.
Executed: 2022-05-27
Assignee
QUIDEL CARDIOVASCULAR INC.
1001 US ROUTE 202, RARITAN, NEW JERSEY, 08869
Covered Properties (17)
Methods for Monitoring the Status of Assays and Immunoassays
Patent: 6,194,222 →
Application: 09/003,065 →
Media Carrier for an Assay Device
Patent: 6,074,616 →
Application: 09/003,066 →
Immunoassay Fluorometer
Patent: 6,830,731 →
Application: 09/003,090 →
Media Carrier for an Assay Device
Patent: 6,392,894 →
Application: 09/545,699 →
Methods for Monitoring the Status of Assays and Immunoassays
Patent: 7,713,703 →
Application: 09/712,615 →
Immunoassay Fluorometer
Patent: 7,416,700 →
Application: 10/267,232 →
Publication: US 2003/0049175
Markers for Differential Diagnosis and Methods of Use Thereof
Patent: 7,713,705 →
Application: 10/330,696 →
Publication: US 2004/0121343
Novel Compositions and Methods for Inhibiting Light-Induced Inactivation of Biological Reagents
Patent: 7,588,908 →
Application: 10/338,182 →
Publication: US 2003/0129642
Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome
Patent: 7,842,472 →
Application: 11/940,111 →
Publication: US 2008/0254485
Methods and Compositions for Diagnosis and Prognosis of Renal Artery Stenosis
Patent: 8,524,462 →
Application: 12/513,499 →
Publication: US 2010/0086944
Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome
Patent: 7,985,560 →
Application: 12/909,654 →
Publication: US 2011/0104726
Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome
Patent: 8,283,128 →
Application: 13/152,009 →
Publication: US 2011/0281280
Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome
Patent: 8,969,018 →
Application: 14/196,346 →
Publication: US 2014/0349868
Microfluidic Device, System and Method
Application: 14/391,643 →
Publication: US 2015/0087079
Test Strip
Patent: 640,389 →
Application: 29/363,033 →
Test Strip Cover
Patent: 639,976 →
Application: 29/363,034 →
Test Strip Base
Patent: 639,977 →
Application: 29/363,035 →
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jul 18, 2012
From: BIOSITE INCORPORATED
To: ALERE SAN DIEGO, INC.
Reel/Frame 028583/0437 →
Assignment of Assignor's Interest Jul 18, 2012
From: VALKIRS, GUNARS; MCPHERSON, PAUL H.
To: BIOSITE INCORPORATED
Reel/Frame 028574/0029 →
Change of Name Jul 16, 2013
From: BIOSITE INCORPORATED
To: ALERE SAN DIEGO, INC.
Reel/Frame 030812/0103 →
Assignment of Assignor's Interest Sep 16, 2014
From: BIOSITE INCORPORATED
To: ALERE SAN DIEGO, INC.
Reel/Frame 033745/0898 →
Security Agreement Sep 16, 2014
From: ADVANTAGE DIAGNOSTICS CORPORATION; ALERE MEDICAL INCORPORATED; ALERE SAN DIEGO, INC.; ALERE SCARBOROUGH, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 033745/0781 →
Assignment of Assignor's Interest Sep 16, 2014
From: VALKIRS, GUNARS; MCPHERSON, PAUL H.
To: BIOSITE INCORPORATED
Reel/Frame 033745/0018 →
Assignment of Assignor's Interest Jan 23, 2015
From: COFFEY, WILLIAM PATRICK; CRIVELLI, PAUL MICHAEL; DERFUS, AUSTIN MATTHEW; DO, TUAN HOANG
To: ALERE SAN DIEGO, INC.
Reel/Frame 034795/0826 →
Notice of Release of Security Interest in Patents Recorded at Reel 026557 Frame 0287 Jun 23, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: ADVANTAGE DIAGNOSTICS CORPORATION; ALERE MEDICAL, INC.; ALERE SAN DIEGO, INC.; ALERE SCARBOROUGH, INC.
Reel/Frame 036011/0581 →
Notice of Release of Security Interest in Patents Recorded at Reel 033745 Frame 0781 Jun 23, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: ADVANTAGE DIAGNOSTICS CORPORATION; ALERE MEDICAL, INC.; ALERE SAN DIEGO, INC.; ALERE SCARBOROUGH, INC.
Reel/Frame 036011/0620 →
Intellectual Property Security Agreement Oct 29, 2015
From: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.)
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 036994/0192 →
Assignment of Ip Security Agreement, Previously Recorded at Reel 036994, Frame 0192 Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING ADMINISTRATIVE AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT
Reel/Frame 037115/0498 →
Release of Security Interest in Intellectual Property Recorded at Reel 036994, Frame 0192 and Reel 037115, Frame 0498 Oct 5, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS COLLATERAL AGENT
To: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.)
Reel/Frame 044213/0258 →
Security Interest Oct 6, 2017
From: QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 043803/0359 →
Triage Assignment, Assumption and Bill of Sale Oct 24, 2017
From: ALERE SAN DIEGO, INC.
To: QUIDEL CARDIOVASCULAR INC.
Reel/Frame 044281/0152 →
Security Agreement May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
Security Agreement Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
Release (Reel 060220 / Frame 0711) Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.
Reel/Frame 072577/0536 →